From: Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort
Pregnancy outcome | AL only | AL & Quinine | Quinine only | SP | Amodiaquine | None |
---|---|---|---|---|---|---|
164 (%) | 8 (%) | 70 (%) | 66 (%) | 11 (%) | 1464 (%) | |
Abortion | 5 (3.0) | 2 (25.0) | 3 (4.3) | 0 (0.0) | 0 (0.0) | 34 (2.3) |
Stillbirth | 6 (3.7) | 0 (0.0) | 5 (7.1) | 2 (3.0) | 0 (0.0) | 49 (3.3) |
Live birth | 153 (93.3) | 6 (75.0) | 62 (88.6) | 64 (97.0) | 11 (100) | 1381 (94.3) |
Birth maturity* | ||||||
Preterm birth | 8 (5.2) | 2 (33.3) | 8 (12.9) | 7 (10.9) | 0 (0.0) | 88 (6.4) |
Full term birth | 145 (94.8) | 4 (66.7) | 54 (87.1) | 57 (89.1) | 11 (100) | 1293 (93.6) |
Birth weight* | ||||||
Low birth weight | 8 (5.2) | 1 (16.7) | 1 (1.6) | 2 (3.1) | 0 (0.0) | 69 (5.0) |
Normal birth weight | 145 (94.8) | 5 (83.3) | 61 (98.4) | 62 (96.9) | 11 (100) | 1312 (95.0) |
Congenital anomalies | 1 (0.6) | 0 (0.0) | 1 (1.4) | 2 (3.0) | 0 (0.0) | 19 (1.3) |